We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

27 hedge funds and large institutions have $8.29M invested in Alimera Sciences in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

8% more funds holding

Funds holding: 25 → 27 (+2)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

54% less capital invested

Capital invested by funds: $17.9M → $8.29M (-$9.57M)

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$166K
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$134K
3
CFFNO
Common Fund For Nonprofit Organizations
Connecticut
+$83.5K
4
Blackstone Inc
Blackstone Inc
New York
+$74K
5
OIA
Optimum Investment Advisors
Illinois
+$35.6K

Top Sellers

Rank Fund Capital Flow
1
PCM
Prelude Capital Management
New York
-$164K
2
PP
PDT Partners
New York
-$161K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$124K
4
Marshall Wace
Marshall Wace
United Kingdom
-$119K
5
DC
Diametric Capital
Massachusetts
-$44.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$2.12M – – –
Morgan Stanley
2
Morgan Stanley
New York
$1.81M +$10K +1,437 +0.3%
PAI
3
Palo Alto Investors
California
$848K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$619K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$598K -$18.9K -2,705 -2%
WVP
6
Worth Venture Partners
New Jersey
$537K – – –
CCPM
7
Cooper Creek Partners Management
New York
$330K – – –
Deutsche Bank
8
Deutsche Bank
Germany
$242K – – –
BCM
9
Bridgeway Capital Management
Texas
$163K – – –
DMK
10
David M. Knott
$162K – – –
BlackRock
11
BlackRock
New York
$124K -$453 -65 -0.2%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$106K – – –
DC
13
Diametric Capital
Massachusetts
$103K -$44.4K -6,369 -21%
JP Morgan Chase
14
JP Morgan Chase
New York
$101K +$166K +23,761 New
PCM
15
Perritt Capital Management
Illinois
$84K – – –
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$81K +$34.2K +4,907 +34%
Ensign Peak Advisors
17
Ensign Peak Advisors
Utah
$81K +$134K +19,151 New
CFFNO
18
Common Fund For Nonprofit Organizations
Connecticut
$50.5K +$83.5K +11,969 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$46K -$124K -17,797 -62%
Blackstone Inc
20
Blackstone Inc
New York
$45K +$74K +10,612 New
OIA
21
Optimum Investment Advisors
Illinois
$34K +$35.6K +5,108 +170%
TRCT
22
Tower Research Capital (TRC)
New York
$7K +$3.78K +542 +57%
GRP
23
Global Retirement Partners
California
$2K – – –
AA
24
Ancora Advisors
Ohio
$1K – – –
PCM
25
Prelude Capital Management
New York
– -$164K -18,036 Closed
1
2

ALIM Hedge Fund Activity: Q3 2021 in Review

27 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2021, worth a combined $8.29M — down 54% from $17.9M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ALIM positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $166K. The largest seller was Prelude Capital Management, exiting entirely with an estimated $164K sold.

  • 27 institutional investors held Alimera Sciences (ALIM) as of Q3 2021, up from 25 in Q2 2021.
  • Funds reported $8.29M of Alimera Sciences stock for Q3 2021, down 54% quarter-over-quarter.
  • 5 funds opened new Alimera Sciences positions in Q3 2021 and 3 closed out, a net change of +2 holders.
  • The largest Alimera Sciences buyer in Q3 2021 was JP Morgan Chase, an estimated $166K added.
  • The largest Alimera Sciences seller in Q3 2021 was Prelude Capital Management, an estimated $164K sold.

Based on aggregated 13F filings for Q3 2021.